The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
about
Oncogenic mutations in GNAQ occur early in uveal melanomaDrosophila as a Potential Model for Ocular TumorsThe genetics of uveal melanoma: current insightsProteomics in uveal melanoma research: opportunities and challenges in biomarker discoveryThe genetics of uveal melanoma: an emerging framework for targeted therapyResistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R.Eye cancer: unique insights into oncogenesis: the Cogan Lecture.Deregulation of the Rb and p53 pathways in uveal melanoma.Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck.High levels of Hdmx promote cell growth in a subset of uveal melanomas.Molecular pathology of uveal melanomaThe relationship between MDM2 expression and tumor thickness and invasion in primary cutaneous malignant melanoma.Targeted silencing of MART-1 gene expression by RNA interference enhances the migration ability of uveal melanoma cellsEmerging insights into the molecular pathogenesis of uveal melanoma.Genetics of uveal melanoma and cutaneous melanoma: two of a kind?Insights into melanoma: targeting the mTOR pathway for therapeutics.Genetic determinants of uveal melanoma.Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma.Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
P2860
Q24658558-1A056403-4FD8-4A6C-9897-3BFCE1761498Q26750375-6FF6BD05-0952-43BE-9DDC-3B3DD6D5166EQ28073150-5544ACEB-C31A-4B3D-8302-2171AEE6BE86Q28297411-B27293EE-D526-44FE-9D7A-FA8C45A88963Q34249080-7596DF5A-A06D-441B-A508-91B3A5796C39Q34745869-DB02A766-D26A-4514-83F0-FBFE886DEC9CQ35585887-AFFBB00E-B361-47D9-B7D5-26C6A26A16FFQ35829776-DD6296B7-C971-4C47-BA4E-D5A148DAE6BEQ36016151-BDC9C827-399A-4C87-9B7F-10E86BADB064Q36206473-5DC31A97-CC96-4639-834C-348CD44A26F4Q36615059-5EB5018C-C645-4ACB-AEFC-27DD743FEA74Q36789792-96DC9AC5-D9F1-4179-96B3-29F7250E8BD4Q37092036-8A9BA435-3D69-4E9B-B450-2134630273FAQ37298647-8B873087-2CF4-4ABD-B935-C26ADBE3A27DQ37772777-A6AD3A81-FDC1-42AA-A73C-991E172045ACQ38012466-6DECBB2F-9AC9-4E3F-9275-CE370B8B510CQ38258203-FDB61546-E11E-4F79-B2BA-B7D22A13D90DQ39396223-0A0D5AFD-0B33-4DE6-A080-1D1CEC54EC91Q41593112-C6425C17-F274-49E3-9825-E415C28D3AD3Q41609825-566181CD-EC51-4013-A8E0-556CEF4EC89FQ43890944-3F3D23CC-3BFC-4387-9292-C055D1DFC85AQ53632901-E3B20EBF-4168-422E-B779-50BDE576F979
P2860
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@en
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@nl
type
label
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@en
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@nl
prefLabel
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@en
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@nl
P2093
P2860
P1476
The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
@en
P2093
G Anastassiou
H Schilling
I Anagnostopoulos
N Bornfeld
S E Coupland
P2860
P304
P356
10.1002/(SICI)1096-9896(200006)191:2<120::AID-PATH591>3.0.CO;2-P
P577
2000-06-01T00:00:00Z